TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $31,925,000 | 48.23% |
| Omega Fund Management, LLC | 2,437,603 | $19,842,000 | 6.32% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $17,768,000 | 2.98% |
| Baupost Group | 17,544,239 | $141,358,000 | 1.56% |
| RTW INVESTMENTS, LP | 3,304,808 | $26,901,000 | 1.02% |
| Camber Capital Management LP | 1,500,000 | $12,210,000 | 0.62% |
| DAFNA Capital Management LLC | 179,845 | $1,464,000 | 0.50% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $3,392,000 | 0.32% |
| Rock Springs Capital Management LP | 950,000 | $7,733,000 | 0.24% |
| Artal Group S.A. | 650,000 | $5,291,000 | 0.20% |